In situ vaccine application of inactivated CPMV nanoparticles for cancer immunotherapy is a research paper published in Materials Advances (2021). On theSindex it has a DataRank of 0. It has been cited 35 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: U01-CA218292
NCI NIH HHS
Grant: U01 CA218292
National Institutes of Health
Grant: 5U01CA218292-03
Overcoming the immune-suppressive tumor microenvironment through in situ vaccination nanotechnology.
FWCI
3.30
Citation Percentile
0.9%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals